Jinan Jinda Pharmaceutical Chemical Co., Ltd. (abbreviated as JDPC) has a 38-year history of specializing in the chemical synthesis of pharmaceutical active ingredients.

Currently, twenty active pharmaceutical ingredient (API) varieties have passed China's GMP certification.

Furazolidone, Dantrolene Sodium, and Nitrofurazone passed on-site FDA inspections in the United States in August 1998, November 2004, and September 2007, respectively. Varieties such as Carprofen, Nitrofurantoin, and Trospium Chloride have submitted DMF/EDMF files. The standard for Carprofen produced by JDPC has been selected as the USP standard.

Over ten products, including Carprofen, Dantrolene Sodium, Nitrofurantoin, Nitrofurazone, Trospium Chloride, Tolperisone, Nylidrin, and Furazolidone, are sold to more than ten countries and regions such as the United States, Japan, Europe, Iran, and Southeast Asia. We have earned the trust and support of excellent clients such as Ratiopharm from Germany; Sanofi-Aventis from France; CW and Neogen from the United States; Eco from the UK; Selectchemie AG from Switzerland; Actavis from Iceland; and Daito from Japan.

JDPC's development positioning is to become a first-class API supplier for regulated markets such as the United States, Europe, and Japan.

Our mission is: "Refining medicine to benefit the world." Our core philosophy is "Benevolence, Positivity, Innovation, Contribution," and "Revere Heaven and Love People." We consistently adhere to the quality policy of "Meticulous Responsibility for a Lifetime" and the action principle of "Sincere Cooperation, Tenfold Effort," implementing these in our business commitments. Gradually, we have formed a management model and corporate culture suitable for our own development, actively striving to realize the beautiful vision of "An Excellent Company, A Century-Old Jinda."

General Manager Ms. Han Yongmei sincerely looks forward to collaborating with you to create a mutually beneficial tomorrow.